254 related articles for article (PubMed ID: 9918198)
41. Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.
Miura I; Graziano SL; Cheng JQ; Doyle LA; Testa JR
Cancer Res; 1992 Mar; 52(5):1322-8. PubMed ID: 1346589
[TBL] [Abstract][Full Text] [Related]
42. Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p.
Miller YE; Minna JD; Gazdar AF
J Clin Invest; 1989 Jun; 83(6):2120-4. PubMed ID: 2542383
[TBL] [Abstract][Full Text] [Related]
43. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
Tran YK; Newsham IF
Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
[TBL] [Abstract][Full Text] [Related]
44. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
[TBL] [Abstract][Full Text] [Related]
45. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
[TBL] [Abstract][Full Text] [Related]
46. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
47. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
48. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
Naylor SL; Johnson BE; Minna JD; Sakaguchi AY
Nature; 1987 Oct 1-7; 329(6138):451-4. PubMed ID: 2821400
[TBL] [Abstract][Full Text] [Related]
49. Three distinct regions involved in 3p deletion in human lung cancer.
Hibi K; Takahashi T; Yamakawa K; Ueda R; Sekido Y; Ariyoshi Y; Suyama M; Takagi H; Nakamura Y; Takahashi T
Oncogene; 1992 Mar; 7(3):445-9. PubMed ID: 1347916
[TBL] [Abstract][Full Text] [Related]
50. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.
Merlo A; Gabrielson E; Mabry M; Vollmer R; Baylin SB; Sidransky D
Cancer Res; 1994 May; 54(9):2322-6. PubMed ID: 8162574
[TBL] [Abstract][Full Text] [Related]
51. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
[TBL] [Abstract][Full Text] [Related]
52. LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines.
Liu CX; Musco S; Lisitsina NM; Forgacs E; Minna JD; Lisitsyn NA
Cancer Res; 2000 Apr; 60(7):1961-7. PubMed ID: 10766186
[TBL] [Abstract][Full Text] [Related]
53. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
[TBL] [Abstract][Full Text] [Related]
54. Allelic deletion mapping on chromosome 5 in human carcinomas.
Wieland I; Böhm M; Arden KC; Ammermüller T; Bogatz S; Viars CS; Rajewsky MF
Oncogene; 1996 Jan; 12(1):97-102. PubMed ID: 8552404
[TBL] [Abstract][Full Text] [Related]
55. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
[TBL] [Abstract][Full Text] [Related]
56. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
57. TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer.
Wu WG; Soria JC; Wang L; Kemp BL; Mao L
Anticancer Res; 2000; 20(6B):4525-9. PubMed ID: 11205299
[TBL] [Abstract][Full Text] [Related]
58. Molecular implications of recurrent cytogenetic alterations in human small cell lung cancer.
Testa JR; Graziano SL
Cancer Detect Prev; 1993; 17(2):267-77. PubMed ID: 8402711
[TBL] [Abstract][Full Text] [Related]
59. Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma.
Mori N; Yokota J; Oshimura M; Cavenee WK; Mizoguchi H; Noguchi M; Shimosato Y; Sugimura T; Terada M
Cancer Res; 1989 Sep; 49(18):5130-5. PubMed ID: 2569931
[TBL] [Abstract][Full Text] [Related]
60. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.
Balsara BR; Sonoda G; du Manoir S; Siegfried JM; Gabrielson E; Testa JR
Cancer Res; 1997 Jun; 57(11):2116-20. PubMed ID: 9187106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
